Navigation Links
GSK Regulatory Update on Avandia Following EMA and FDA Reviews
Date:9/23/2010

LONDON, Sept. 23 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE and LSE: GSK) confirms that following a review of Avandia® (rosiglitazone maleate) by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), each agency has today announced their individual regulatory decisions and the resulting actions.  

In the European Union*, the EMA has suspended the marketing authorization for all rosiglitazone-containing medicines (Avandia, Avandamet® and Avaglim®).  As a result, physicians in Europe are being advised that affected patients need to be transitioned to alternative treatment options.  The EMA have stated that the suspension will remain in place unless convincing data are provided that identify a group of patients in whom the benefits of the medicine outweigh its risks.

In the US, all rosiglitazone-containing medicines (Avandia, Avandamet and Avandaryl®) will remain available with additional safety labeling and restrictions for use. The FDA will also require a Risk Evaluation and Mitigation Strategy (REMS) program with additional measures to ensure the safe use of the medicine.

Dr. Ellen Strahlman, GSK's Chief Medical Officer, said: "Our primary concern continues to be patients with type 2 diabetes and we are making every effort to ensure that physicians in Europe and the US have all the information they need to help them understand how these regulatory decisions affect them and their patients."

The company continues to believe that Avandia is an important treatment for patients with type 2 diabetes and is now working with the FDA and EMA to implement the required actions.  GSK will also work closely with other regulatory agencies to comply with any decisions made by them regarding rosiglitazone-containing medicines. GSK will voluntarily cease promotion of Avandia in all the countries in which it operates and will continue to respond to requests for informatio
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EpiCept Reports Regulatory Progress on Ceplene(TM)
2. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
3. Anesiva Defines Regulatory Pathway for Adlea with FDA
4. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
5. EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream
6. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
7. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
8. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
9. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
10. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
11. XTENT Announces European Regulatory Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  BioLife Solutions, Inc. (NASDAQ: BLFS ), a ... hypothermic storage and cryopreservation freeze media and ... ("BioLife" or the "Company"), announced that the Company is scheduled ... The Company is scheduled to present at the Conference ... the Grand Hyatt Hotel in New York City ...
(Date:5/22/2015)... The North American dental lasers market ... to reach $90.7 million by 2019, at a CAGR of ... TOC of North America Dental Lasers Market for an analysis ... tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ...   Dental lasers are specifically used in ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015 /PRNewswire/ ... "RegeneRx") today announced a peer-reviewed publication of the ... study evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for ... Inc.,s controlled adverse environment (CAE ® ) model.  ... and the results, which were previously disseminated by ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4
... AMGN ) today announced that the company will ... the Amgen Foundation will distribute the funds to both Direct ... and vital health services to those affected in Japan. ... partnership with Kirin Holding and its pharmaceutical affiliate Kyowa Hakko ...
... Reportlinker.com announces that a new market research report ... Market for Dental Prosthetics and CAD/CAM Devices 2011 ... market for dental prosthetics was the third largest dental ... of the growing number of private practices in the ...
Cached Medicine Technology:Amgen Donates $1 Million to Help Japanese Disaster Victims 2Reportlinker Adds U.K. Market for Dental Prosthetics and CAD/CAM Devices 2011 2Reportlinker Adds U.K. Market for Dental Prosthetics and CAD/CAM Devices 2011 3Reportlinker Adds U.K. Market for Dental Prosthetics and CAD/CAM Devices 2011 4Reportlinker Adds U.K. Market for Dental Prosthetics and CAD/CAM Devices 2011 5Reportlinker Adds U.K. Market for Dental Prosthetics and CAD/CAM Devices 2011 6
(Date:5/22/2015)... 2015 River Valley Health Partners (RVHP) ... health system’s Chief Financial Officer (CFO), will be leaving ... as the company CFO since 2011. , The Board ... the health system as CFO. Wesley will oversee the ... the Board of Trustees conducts a formal search for ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will likely ... pulmonary disorder (COPD) as the dominant companies like ... well as Germany’s Boehringer Ingelheim compete with each ... market payers, clinicians and patients be disposed to ... new ones? , In spite of recently approved ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Carnegie ... today announced a new partnership to develop BodyTech, ... the region. The initiative includes a new exhibit at ... live demonstration theater, and a new traveling science show, ... fall of 2015. , Designed to explore a ...
(Date:5/22/2015)... 2015 Power Systems is proud to announce ... race season. Drobeck is in his second year of racing ... with the Missoula Fire Department in Missoula, MT. He entered ... 2014. During his career, he has had 15 1st Place ... top 10 finishes in all seven of his 2014 races, ...
(Date:5/22/2015)... Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they are ... cosmetic, restorative and other dental treatments. At consultations, ... interest them. Questions regarding what certain treatments can ... also be covered during this initial appointment. If ...
Breaking Medicine News(10 mins):Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2
... ... the job before you even sit down for your interview. One Portland, Oregon business ... ... the PostureNOW posture corrective brace ( www.posturenow.com ), today announced a special discount offer ...
... ... ... 24, 2010 -- Edmonton Research Park based company Sino Veda is revolutionizing ... have been used around the world for centuries, only recently has modern medicine been ...
... , ... Inc. announces their award of laboratory accreditation by COLA, a national healthcare accreditation organization. ... (PRWEB) March ... the Laboratory Excellence Award, for outstanding performance in quality patient testing and overall exemplary ...
... ... to switch off ensuring lights go out across every continent. More than 118 countries and ... action on climate change., , ... (PRWEB) March 24, 2010 -- China’s most significant historic landmark, the Forbidden City in Beijing, ...
... , ... 17th Annual CFO Rising Conference & Exhibition, leading corporate finance executives agreed that the ... the role of the federal government. , ... New York (PRWEB) March 24, 2010 -- At the ...
... ... you join in recognizing all physicians on National Doctor,s Day, March 30 -- for their ... ... is National Doctor’s Day. The American Board of Physician Specialties (ABPS) asks that ...
Cached Medicine News:Health News:Your Posture Can Make or Break Your Job Interview; PostureNOW Offers 33% Off Its Posture Corrective Brace to Job Seekers Nationwide 2Health News:Sino Veda Herbal Product Maker Goes Natural in Edmonton Research Park 2Health News:US Wellness, Inc. Receives National Recognition for Laboratory Excellence 2Health News:China's Forbidden City Leads Landmark Climate Action for Earth Hour 2Health News:China's Forbidden City Leads Landmark Climate Action for Earth Hour 3Health News:China's Forbidden City Leads Landmark Climate Action for Earth Hour 4Health News:The Worst Is Over, but the Road to Growth Is Uncertain - The 17th Annual CFO Rising Conference & Exhibition 2Health News:The Worst Is Over, but the Road to Growth Is Uncertain - The 17th Annual CFO Rising Conference & Exhibition 3Health News:American Board of Physician Specialties (ABPS) Celebrates Doctor's Day 2010 2
... TST 40 tissue stainer is an "assembly-line ... in histology and cytology laboratories. Programmable continuous ... stains big quantities of slides in short ... in combination with a continuous working principle ...
DS 100, double side an economical, easy-to-use instrument for the automatic staining in histology and cytology....
Cholesterol, Total. An automated analyzer test kits....
For the quantitative determination of total cholesterol in serum....
Medicine Products: